Biotech

Latest Articles

Cassava spends $40M over supposedly misleading Alzheimer's update

.Cassava Sciences has actually accepted pay out $40 million to deal with an investigation right into...

Merck bags choices on Evaxion's AI-designed vaccine candidates

.Merck &amp Co. has gotten alternatives on pair of Evaxion Biotech injection candidates, spending $3...

Enanta's RSV antiviral crushes viral tons in obstacle research study

.Enanta Pharmaceuticals has actually linked its own respiratory syncytial infection (RSV) antiviral ...

Biogen cans SAGE-324 collaboration after crucial shake neglect

.Biogen has conducted the final rites to its cooperation along with Sage Therapies on SAGE-324, scra...

AbbVie Parkinson's drug coming from $8.7 B Cerevel buyout scores

.On the exact same day that some Parkinson's condition medications are actually being actually calle...

Arch finalizes $3B-plus fund to cultivate biopharma upstarts

.On the heels of a $3 billion fund coming from Bain Funding Life Sciences, Arc Project Partners is a...

Orion to use Aitia's 'electronic identical twins' to find brand new cancer cells drugs

.Finnish biotech Orion has actually snooped possible in Aitia's "digital identical twin" specialist ...

Windtree's surprise med raises blood pressure in most recent stage 2 win

.While Windtree Therapies has struggled to increase the monetary roots needed to have to endure, a s...

2 cancer biotechs combine, developing international impact

.OncoC4 is actually taking AcroImmune-- and also its in-house clinical manufacturing capabilities-- ...

Amgen records 1st phase 3 win for $400M dermatitis drug

.Amgen has discussed (PDF) the very first period 3 data on its $400 million eczema drug, linking the...

Biogen, UCB document period 3 lupus win after failing earlier trial

.Biogen and UCB's gamble on improving right into period 3 astride a broken study aims to have actual...

Aptadir really hopes brand-new RNA preventions can easily turn around tricky cancers

.Italian biotech Aptadir Therapeutics has actually launched with the assurance that its own pipeline...

Wave surfs DMD results to regulatory authorities' doors, sending stockpile

.Wave Lifestyle Sciences has met its own objective in a Duchenne muscular dystrophy (DMD) study, pos...

Sanofi picks new CSO from in-stealth biotech

.After a handful of years in biotech, Mike Quigley, Ph.D., is actually going back to the pharma laye...

Achilles trickles tissue treatment course, braces for discharges after missing 'industrial practicality' targets

.Achilles Therapeutics has destroyed its strategy. The English biotech is actually quiting working o...

Aligos heralds stage 2 MASH gain, reducing liver body fat approximately 46%

.Aligos Therapies is heralding a midstage win in metabolic-dysfunction associated steatohepatitis (M...

Basilea ratings $268M BARDA funding for antifungals, prescription antibiotics

.Basilea Pharmaceutica's work cultivating brand-new antifungals has gotten a substantial increase fr...

Capricor sells Europe legal rights to late-stage DMD therapy for $35M

.Having currently scooped up the united state civil rights to Capricor Rehabs' late-stage Duchenne m...

FDA scraps adcomm for Applied's rare disease medication

.After pushing back the decision date for Applied Therapeutics' metabolic disorder medication govore...

Novo inks $600M NanoVation deal to research genetic medications ex-liver

.Novo Nordisk is continuing its own press right into hereditary medicines, accepting to compensate N...